Home
Business
Metro
Nation
World
Sports
Feature
Opinion
View more »Opinion Columns
Wan LixinOpinion deputy editor of Shanghai Daily
Fulsome tribute to supervisor in paper draws ire
On extending employment benefits to gig workers
Sunday
- Subscribe
Clinical trials for coronavirus drug
Print Edition
SHANGHAI has launched clinical trials to test the efficiency of an anti-rheumatic drug in the treatment of novel coronavirus pneumonia, according to academician Chen Kaixian.
As yet, there is no specific medicine for treating the virus. As new drug development takes time, local scientists have been researching existing drugs in the possible treatment of the coronavirus, Chen, of the China Academy of Social Sciences, said at a press conference yesterday.
Hydroxychloroquine, which can decrease the pain and swelling caused by arthritis, has been approved for clinical trials by the Ministry of Science and Technology and the National Health Commission.
Shanghai Pharmaceuticals Holding Co and the Shanghai Institute of Materia Medica under the CAS are carrying out the tests at the Shanghai Public Health Clinical Center.
“Medicines are key weapons against the novel coronavirus, and they are urgently needed. Researchers are racing against the clock to find an effective treatment. But it takes a long time,” Chen said.
Despite the difficulties, Shanghai researchers have made some progress in the drug’s development.
Researchers from ShanghaiTech University have revealed the high-resolution crystal structure of the viral main proteinase (Mpro) of the novel coronavirus. The Mpro, which controls the activities of the coronavirus replication complex, is an attractive target for therapy.
Also, the two P3 laboratories of Fudan University and the Shanghai Disease Control and Prevention Center have isolated four new coronavirus strains. Chen said their work has greatly promoted the development of new drugs.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
